MiMedx Group, Inc. (MDXG)
4.12
-0.05
(-1.20%)
USD |
NASDAQ |
Mar 20, 16:00
4.13
+0.01
(+0.24%)
After-Hours: 20:00
MiMedx Group Profit Margin (Quarterly) : 12.86% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 96.33% |
| ADMA Biologics, Inc. | 35.48% |
| Viridian Therapeutics, Inc. | -77.26K% |
| Arcus Biosciences, Inc. | -321.2% |
| Mirum Pharmaceuticals, Inc. | -3.85% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 21.92% |
| Return on Assets | 16.33% |
| Return on Invested Capital | 20.06% |
| Gross Profit Margin (Quarterly) | 83.76% |
| Operating Margin (Quarterly) | 17.85% |
| Return on Net Operating Assets | 33.77% |